Table 2 Surgery data between patients with PEEK and BGC group.

From: Clinical and radiological outcomes of non-window-type bioactive glass–ceramic cage in single-level ACDF versus PEEK cage filled with autologous bone

 

PEEK group (n = 19)

BGC group (n = 20)

P-value

Operative time (min)

105.57 ± 14.80

75.80 ± 16.05

< 0.001

Intraoperative blood loss (mL)

75.26 ± 75.74

58.25 ± 53.29

0.42

Blood transfusion (number of patients)

0

0

 

Inter-spinous motion at post-operative 1 year (mm)

0.54 ± 0.37

0.54 ± 0.37

0.562

Bone bridging formation at post-operative 1 year (Y/N)

18/19 (94.7%)

19/20 (95.0%)

0.970

Causes of intra-operative/post-operative adverse events

 Dural tear (n)

0

0

 

 Post-operative neurologic deficit (n)

0

0

 

 Deep wound infection (n)

0

0

 

 Pseudoarthrosis (n)

1 (5.3%)

1 (5.0%)

0.970

 Subsidence (n)

0

0

 

 Reoperation due to perioperative adverse events

0

0

 

 Readmission due to perioperative adverse events

0

0

 
  1. Values are expressed as number of patients or percentages. Continuous variables, including operative time, blood loss, and inter-spinous motion, were analyzed using a t-test. Categorical variables, including blood transfusion, bone bridging formation, adverse events, reoperation, and readmission, were analyzed using the χ2 test.